| CYSB2400064 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-03-09 | | | | | view |
| CYSB2101013 | 重组人促红素注射液(CHO细胞) | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-03-22 | | Beijing Four Rings Bio-Pharmaceutical Co Ltd | | | view |
| JYSB2200153 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2022-08-12 | | | | | view |
| J0401452 | 重组人红细胞生成素-beta 注射液 | | Injection | Biological Products | Supplementary Application | 2004-08-12 | | Shanghai Roche Pharmaceuticals Ltd Beijing | Certificate Issued | 2005-05-09 | view |
| JYSZ2200042 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | License Renew | 2022-08-30 | | | | | view |
| JXSL1000034 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Import Drug Application | 2010-08-04 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2013-02-19 | view |
| CYSB2400178 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-07-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2101254 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-11-04 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| JYSZ0800024 | 注射用重组人红细胞生成素 | Recombinant Human Erythropoietin(CHO Cell) | Lyophilized | Biological Products | License Renew | 2008-02-22 | | Biosidus SA | Certificate Issued | 2019-03-21 | view |
| CYSB2200264 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-11-22 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2200100 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-03-30 | | Kexing Biopharm Co Ltd | | | view |
| CYSB2400204 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-08-08 | | NCPC Genetech BIOTECHNOLOGY Co Ltd | | | view |
| JYSB2101070 | 重组人促红素-β注射液(CHO细胞) | Recombinant Human Erythropoietin β(CHO Cell) | Injection | Biological Products | Supplementary Application | 2021-06-30 | | | | | view |
| JYSB2300072 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2023-04-26 | | | | | view |
| CYSB2101009 | 重组人促红素注射液(CHO细胞) | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2021-03-22 | | Beijing Four Rings Bio-Pharmaceutical Co Ltd | | | view |
| JYSB2300071 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Supplementary Application | 2023-04-26 | | | | | view |
| JYSB2200127 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-07-14 | | | | | view |
| JXSS1300007 | 甲氧聚二醇重组人促红素注射液 | | Injection | Biological Products | Import Drug Application | 2013-06-18 | | | Certificate Issued | 2018-05-24 | view |
| JYSB2101197 | 重组人促红素-β注射液(CHO细胞) | Recombinant Human Erythropoietin β(CHO Cell) | Injection | Biological Products | Supplementary Application | 2021-12-17 | | | | | view |
| CYSB2400129 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products(3.4) | Supplementary Application | 2024-05-22 | | | | | view |
